These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3926645)

  • 1. Prevention of urinary tract infection in rats with an indigenous Lactobacillus casei strain.
    Reid G; Chan RC; Bruce AW; Costerton JW
    Infect Immun; 1985 Aug; 49(2):320-4. PubMed ID: 3926645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments.
    Chan RC; Reid G; Irvin RT; Bruce AW; Costerton JW
    Infect Immun; 1985 Jan; 47(1):84-9. PubMed ID: 3917428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract.
    Reid G; Cook RL; Bruce AW
    J Urol; 1987 Aug; 138(2):330-5. PubMed ID: 3599250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections.
    Bruce AW; Reid G
    Can J Microbiol; 1988 Mar; 34(3):339-43. PubMed ID: 3138016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence of cervical, vaginal and distal urethral normal microbial flora to human uroepithelial cells and the inhibition of adherence of gram-negative uropathogens by competitive exclusion.
    Chan RC; Bruce AW; Reid G
    J Urol; 1984 Mar; 131(3):596-601. PubMed ID: 6422061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of growth media on the morphology and in vitro adherence characteristics of gram-negative urinary pathogens.
    Chan RC; Bruce AW
    J Urol; 1983 Feb; 129(2):411-7. PubMed ID: 6403715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence of gram-negative uropathogens to human uroepithelial cells.
    Polito M; Minardi D; Montanari MP; Varaldo PE
    Eur Urol; 1987; 13(1-2):74-8. PubMed ID: 3107998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection.
    Asahara T; Nomoto K; Watanuki M; Yokokura T
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1751-60. PubMed ID: 11353622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactobacillus inhibitor production against Escherichia coli and coaggregation ability with uropathogens.
    Reid G; McGroarty JA; Angotti R; Cook RL
    Can J Microbiol; 1988 Mar; 34(3):344-51. PubMed ID: 3138017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commensal Urinary Lactobacilli Inhibit Major Uropathogens
    Johnson JA; Delaney LF; Ojha V; Rudraraju M; Hintze KR; Siddiqui NY; Sysoeva TA
    Front Cell Infect Microbiol; 2022; 12():870603. PubMed ID: 35811675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin.
    Hagberg L; Engberg I; Freter R; Lam J; Olling S; Svanborg Edén C
    Infect Immun; 1983 Apr; 40(1):273-83. PubMed ID: 6339403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot Ex Vivo and In Vitro Evaluation of a Novel Foley Catheter with Antimicrobial Periurethral Irrigation for Prevention of Extraluminal Biofilm Colonization Leading to Catheter-Associated Urinary Tract Infections (CAUTIs).
    Vargas-Cruz N; Rosenblatt J; Reitzel RA; Chaftari AM; Hachem R; Raad I
    Biomed Res Int; 2019; 2019():2869039. PubMed ID: 31976318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence of gram-negative uropathogens to human uroepithelial cells.
    Bruce AW; Chan RC; Pinkerton D; Morales A; Chadwick P
    J Urol; 1983 Aug; 130(2):293-8. PubMed ID: 6135810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in biosensor based diagnosis of urinary tract infection.
    Kumar MS; Ghosh S; Nayak S; Das AP
    Biosens Bioelectron; 2016 Jun; 80():497-510. PubMed ID: 26890825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Characterization of
    Kyser AJ; Mahmoud MY; Johnson NT; Fotouh B; Steinbach-Rankins JM; Gilbert NM; Frieboes HB
    ACS Biomater Sci Eng; 2023 Jul; 9(7):4277-4287. PubMed ID: 37367532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptozocin-induced diabetic mouse model of urinary tract infection.
    Rosen DA; Hung CS; Kline KA; Hultgren SJ
    Infect Immun; 2008 Sep; 76(9):4290-8. PubMed ID: 18644886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of lactobacillus strains against uropathogens.
    Shim YH; Lee SJ; Lee JW
    Pediatr Int; 2016 Oct; 58(10):1009-1013. PubMed ID: 26865336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive and therapeutic administration of an indigenous Lactobacillus sp. strain against Proteus mirabilis ascending urinary tract infection in a mouse model.
    Fraga M; Scavone P; Zunino P
    Antonie Van Leeuwenhoek; 2005 Jul; 88(1):25-34. PubMed ID: 15928974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of type 1 and P fimbriae in situ and localisation of a uropathogenic Escherichia coli strain in the murine bladder and kidney.
    Connell H; Poulsen LK; Klemm P
    Int J Med Microbiol; 2000 Dec; 290(7):587-97. PubMed ID: 11200540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of uropathogenic Escherichia coli metapopulation movement during urinary tract infection.
    Walters MS; Lane MC; Vigil PD; Smith SN; Walk ST; Mobley HL
    mBio; 2012; 3(1):. PubMed ID: 22318320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.